Jenny L. Wiley

Best Publications

• Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo

  Jonathan Z. Long;Daniel K. Nomura;Robert E. Vann;D. Matthew Walentiny

  452
  Citations

• Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists.

  John W. Huffman;Gulay Zengin;Ming-Jung Wu;Jianzhong Lu

  355
  Citations

• Sex differences in cannabinoid pharmacology: A reflection of differences in the endocannabinoid system?

  Rebecca M. Craft;Julie A. Marusich;Jenny L. Wiley

  331
  Citations

• Structure-activity relationships of indole- and pyrrole-derived cannabinoids.

  Jenny L. Wiley;David R. Compton;Dong Dai;Julia A. H. Lainton

  321
  Citations

• Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.

  Melisa J Wallace;Jenny L Wiley;Billy R Martin;Robert J DeLorenzo

  268
  Citations

• Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia

  Unknown

  261
  Citations

• CB1 cannabinoid receptor-mediated modulation of food intake in mice

  Jenny L Wiley;James J Burston;Darnica C Leggett;Olga O Alekseeva

  246
  Citations

• Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV)

  Julie A. Marusich;Kateland R. Antonazzo;Jenny L. Wiley;Bruce E. Blough

  231
  Citations

• Synthesis and Pharmacology of a Very Potent Cannabinoid Lacking a Phenolic Hydroxyl with High Affinity for the CB2 Receptor

  John W. Huffman;Shen Yu;Vincent Showalter;Mary E. Abood

  216
  Citations

• Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids.

  Jenny L. Wiley;Julie A. Marusich;John W. Huffman

  212
  Citations

• 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles.

  John W. Huffman;Paul V. Szklennik;Amanda Almond;Kristen Bushell

  203
  Citations

• Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines

  Michael H. Baumann;Ernesto Solis;Lucas R. Watterson;Julie A. Marusich

  202
  Citations

• 3-Indolyl-1-naphthylmethanes: New Cannabimimetic Indoles. Provide Evidence for Aromatic Stacking Interactions with the. CB1 Cannabinoid Receptor

  John W. Huffman;Ross Mabon;Ming-Jung Wu;Jianzhong Lu

  194
  Citations

• Cannabinoid pharmacological properties common to other centrally acting drugs.

  Jenny L. Wiley;Billy R. Martin

  194
  Citations

• Regional enhancement of cannabinoid CB1 receptor desensitization in female adolescent rats following repeated Δ9-tetrahydrocannabinol exposure

  James J Burston;James J Burston;Jenny L Wiley;Jenny L Wiley;Abimbola A Craig;Dana E Selley

  192
  Citations

• A Cannabinoid CB1 Receptor Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with no Psychoactive Effects

  Bogna M Ignatowska-Jankowska;Gemma L Baillie;Steven Kinsey;Molly Crowe

  186
  Citations

• Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys.

  J L Wiley;J A Lowe;R L Balster;B R Martin

  184
  Citations

• Effects of synthetic cathinones contained in "bath salts" on motor behavior and a functional observational battery in mice.

  Julie A. Marusich;Kateland R. Grant;Bruce E. Blough;Jenny L. Wiley

  180
  Citations

• Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice.

  Jenny L. Wiley;Anthony F. Cristello;Robert L. Balster

  170
  Citations

• Interactions between THC and cannabidiol in mouse models of cannabinoid activity.

  SA Varvel;Jenny Wiley;R Yang;DT Bridgen

  163
  Citations